Following the backlash to an exclusive shareholder event from Namaste Technologies (TSXV:N), the company said it does not regret hosting the event and issued a response to shareholders regarding the controversy.

Last Wednesday (September 12), Namaste hosted a party in Montreal, Quebec rewarding investors for completing a pledge to hold or increase their position in the company since May in an effort to combat market short sellers.

On Sunday (September 16), during a live stream video, Sean Dollinger, CEO of Namaste, told shareholders they can be “confident” nothing has changed for the company despite losing a deal with Canadian licensed producer (LP) Tilray (NASDAQ:TLRY) as a result of the event.

“There’s always going to be people trying to throw us off the top. It’s happened before, it happened now and it’s going to keep happening,” Dollinger said during his Namaste 420 Live YouTube show.

“As long as we are the most exciting company in this space we will always have people trying to cause disruption,” he continued. The executive of the company guaranteed to the audience he will not let go of the investors’ money and trust.

Namaste’s YouTube channel had an uploaded video of the event showing investors and company executives celebrating the end of the pledge. Interviews with shareholders showing support for the company were also added to the video. The video was later removed from Namaste’s account.

Investor party leads to Quebec reaction and Tilray drop

Kory Zelickson, co-founder of Namaste, told the Investing News Network (INN) Namaste does not regret hosting the pledge party for its shareholders.

However he apologized for reports showing hired models dressed as nurses. Reportedly the models acting as nurses were offering to register party attendees as medical users for Namaste’s services. According to a report from La Presse, other models were seen offering adult-use cannabis products.

“If that offended anybody, which I can certainly understand, we are very much apologetic for that,” Zelickson said of the models dressed as nurses.

Namaste argued against the claims of recreational cannabis sales and said its entire Canadian play focuses on the medical market through its producer subsidiary Cannmart, which is awaiting for confirmation of a sales license in Canada.

The party and the report from La Presse caused the Société des alcools du Québec (SAQ), the agency tasked with regulating recreational cannabis use in the province, to challenge the validity of the the event from Namaste and the reported distributed cannabis.

SAQ spokeswoman Linda Bouchard told La Presse there was zero tolerance to the tactics employed by Namaste at the event. The SAQ also issued a warning to Canadian licensed producer (LP) Tilray since the company had signed a sales agreement with Namaste.

“A producer who does business with us cannot be associated with a company that is against the law,” Bouchard added. “Our partners must comply. We must be firm.”

Tilray proceeded to drop Namaste’s agreement. In a statement to INN, the company said:

We were not aware of and did not approve Namaste’s recent promotional activities. We do not believe these types of activities will further legitimize medical cannabis with the medical community.

Namaste contested it only operates in the medical cannabis market through its service and did not infringe in the rules from Quebec at its event.

When asked if the company had time to make its case to Tilray, Zelickson said the producer offered no notice or cause in its termination. The executive guessed Tilray was “strong-armed” to drop Namaste by Quebec.

“It would have been great to work with Tilray, it’s unfortunate that it happened and I can understand their position, if they were feeling the pressure they have to do what’s best for their shareholders,” Zelickson told INN.

In September the two cannabis companies confirmed a purchase agreement in which Namaste would buy “bulk medical cannabis products” from Tilray, for an undisclosed amount for Cannmart.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

Dollinger stated the drop from Tilray “does not in any way affect our business strategy, operations or anticipated revenues,” since the company has “enough” supply from other Canadian LPs.

Zelickson added Namaste is seeking a public apology from SAQ on the comments made about the company. Zelickson said the company is considering legal action against La Presse as well.

Investor pledge raises questions

Launched on May 18, alongside both co-founders and executives Dollinger and Zelickson, the Namaste pledge asked investors to join and guarantee to only hold or increase their shares in the company over 90 days.

At the pledge’s launch Dollinger told the Globe and Mail company lawyers had confirmed the promotion as a legal resource for the company.

According to Zelickson, over 150 million shares of Namaste were pledged.

Investor takeaway

Namaste holders took a hit during the early trading session but managed to rally for a positive close. Shares of the company closed at a price of C$2.96, representing a 4.23 percent increase.

Shares of Tilray suffered a quick drop on Monday morning, only to recover and even continue its monumental growth path of the past month.

The company finished the day with a 2.22 percent increase to reaching a share price of US$119.73. During after hours trading, Tilray was down 0.74 percent.

Don’t forget to follow us @INN_Cannabis for real-time news updates and stay tuned for cannabis stories from the MoneyShow!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), announced today that it has re-filed its unaudited condensed interim consolidated financial statements, together with the notes thereto, for the three and six months ended June 30, 2020 and 2019 (the “ Interim Financial Statements ”) to correct, among other things, certain 2019 comparative period information and to update certain presentation arising from the Company’s early adoption of IFRS 3 in late 2019, which changes were identified in connection with the Company’s review engagement with its auditor. The Company does not consider these adjustments either individually nor in the aggregate, to be material.

The re-filed Interim Financial Statements reflect changes to the Condensed Interim Consolidated Statements of Loss and Comprehensive Loss comparative period to remove transaction fees from the income statement and capitalize them to the applicable acquisition in accordance with the Company’s early adoption of the amended IFRS 3 as set out in Note 2, and to reclassify $1 million from general and administrative expenses to transaction fees for presentation purposes to conform with the Company’s presentation used in its audited consolidated financial statements for the years ended December 31, 2019 and 2018 (the “ Audited Annual Financial Statements ”). The re-filed interim Financial Statements also reflect changes to the Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity to correct the 2019 comparative period balances as they incorrectly reflect Q1 2019 period balances, update certain presentation to conform with the Company’s presentation used in its Audited Annual Financial Statements; and reduce the valuation conclusion of the Company’s acquisition of NettaGrowth International Inc. to conform with the Audited Annual Financial Statements. The re-filed Interim Financial Statements also bring forward the subsequent event note disclosure.

Keep reading... Show less

Part of “Rooted in Good” CSR Platform, “Feed the Block” Gives Back Through Strategic Social Partnerships with Local Organizations Focused on Food Insecurity

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced a multi-state fundraising initiative in which proceeds will benefit 24 locally run food banks, homeless shelters and nonprofits working to proactively address the needs of those facing food insecurity in communities across America. This effort is a part of the Strategic Social Partnerships pillar within Curaleaf’s “Rooted in Good” Corporate Social Responsibility platform.

Keep reading... Show less

On September 8, 2020, Aurora Cannabis Inc. (NYSE:ACB) stunned the market when it announced that it expected to record up to $1.8 billion in goodwill impairment charges in the fourth quarter of 2020. On the same day, Aurora also announced a charge of approximately $140 million in the carrying value of certain inventory, and that it was appointing a new chief executive officer. On this news, Aurora’s stock fell approximately 11.6% in just one day. Since May 2020, Aurora’s stock is down approximately $10.00 per share

A lawsuit alleging violations of federal securities laws has been filed against Aurora and certain of its officers and directors. The suit alleges, among other things, that Aurora misled investors as to the value of prior acquisitions, that the Company had experienced degradation in certain assets, and that as a result, it was foreseeable that Aurora would record significant goodwill and asset impairment charges. According to the lawsuit, this news was so shocking because Aurora had previously lauded a “business transformation plan” that would purportedly “better align the business financially with the current realities of the cannabis market.”

Keep reading... Show less

  • Exclusive patent licensed from University of Idaho.
  • Mustard-derived fumigation of stored food – targeting vegetables and potatoes.
  • Leading agrochemical for sprout suppression – chlorpropham – banned by European Union on Oct. 8, 2020.
  • Appointment of Scientific Advisor Dr. Matthew J. Morra, professor emeritus of soil biochemistry at University of Idaho.

 MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce the exclusive patent licensing from the University of Idaho pertaining to a natural biopesticide mustard-based treatment of stored produce and other foods, particularly sprout suppression of potatoes.

Keep reading... Show less

Study represents the first research completed on the long-term toxicity and lifespan effects of cannabidiol in the preclinical model C. elegans

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) and its medical division, Spectrum Therapeutics, have completed and published a new study on the long-term effects of cannabidiol (CBD), specifically focusing on toxicity and lifespan effects of CBD in the preclinical model C. elegans.

Keep reading... Show less